Postpartum depression affects many new mothers, increasing suicide risk. New research shows preventive cognitive behavioral ...
Exploring new treatment avenues has become crucial as mental health challenges such as depression and PTSD continue impacting ...
The U.S. Food and Drug Administration approved Johnson & Johnson's ketamine-based nasal spray Spravato to treat adults with ...
For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...
A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression ...
Using computational models, the researchers studied how the brain's reward-learning system functions in those with depression, especially among individuals experiencing anhedonia, the inability to ...
The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for ...
Mental Health America predicts that nearly 60 million Americans suffered from a mental illness in 2024, and research from the ...
The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...